The 22nd CardioVascular Summit-TCTAP 2017 will open for a three-day run on April 25 at Coex, southern Seoul. CardioVascular Research Foundation will host the annual event, and Heart Institute of Asan Medical Center will sponsor it.
The officially titled International Congress on Coronary Artery Intervention (TCTAP) held its inaugural meeting at Asan Medical Center in 1995 and has since become a leading venue for the training of cardiovascular interventional procedure in the Asia-Pacific region, attracting more than 4,000 cardiovascular experts from 50 countries, the official said.
The conference will focus on the treatment of various heart ailments, including coronary artery disease and valvular diseases, such as left-sided liver disease and chronic obstructive pulmonary disease, carotid and abdominal aortic aneurysmal treatment, lower angioplasty, cardiovascular imaging and physiology, drug-eluting stent and biomedical scaffold, and structural heart disease.
|World-renowned hospitals demonstrate live procedures through real-time satellite during the CardioVascular Summit 2016.|
The event will comprise sessions dealing with a wide scope of subjects, ranging from basic knowledge to in-depth study on current research trends.
The main program of the conference is live medical practice. The sessions include cardiology in the United States, Canada, Italy, China, and Korea. World-renowned hospitals, domestic and abroad, will demonstrate live procedures through real-time satellite.
On the opening day, they will operate Chronic Obstruction Lesion (CTO) Interventional Surgery Society on a one-day course in cooperation with the Asian CTO Club.
Also, there will be a symposium on partnership sessions and endovascular therapies, run by related societies and associations. The thematic workshop will also provide a place to learn the basics of cardiac intervention.
On the second and third day, the Symposium on Coronary Disease and Valvular Heart Disease will focus on live demonstrations and topics of particular interest in academia in depth. Researchers at Asan Medical Center will also present their latest research results.
Through the abstract and case presentation contest, the organizers will offer young scientists the chance to exchange opinions with the world's scholars. They will also select the recipients of the 7th 'Master of Masters' along with the 5th TCTAP Best Young Scientist Award to encourage the next generation of researchers who will lead the future cardiovascular disease research.
Also included are cardiovascular technology research symposium for cardiovascular nurses and radiologists and a free heart disease prevention event for the general public.
<© Korea Biomedical Review, All rights reserved.>